Anika Therapeutics Inc (ANIK) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $12.79
• Market Cap: $157.77M
• EPS: $-0.99
• 52-Week High: $17.74
• 52-Week Low: $7.87

Market Sentiment

Anika Therapeutics Inc currently has a Bullish sentiment score of 0.18.

About Anika Therapeutics Inc

Anika Therapeutics Inc. is a leader in joint preservation and regenerative therapies, focusing on innovative orthopedic solutions that enhance patient mobility and reduce pain. Headquartered in Bedford, Massachusetts, the company has established a strong presence in key markets including the U.S. and Europe. Anika's portfolio primarily consists of hyaluronic acid-based therapeutics, specifically targeting osteoarthritis and joint disorders, which strategically positions the firm within the ex...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Anika Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANIK pay dividends?

Anika Therapeutics Inc (ANIK) does not currently pay a regular dividend.

What is ANIK's market cap?

Anika Therapeutics Inc (ANIK) has a market capitalization of $157.77M with a current stock price of $12.79.